Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Ciriello

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Cell|August 10, 2019
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-KinaseViraj R Sanghvi, Josef Leibold, Marco Mina, et al.
American Journal of Human Genetics|October 18, 2016
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome SequencingBeryl Royer-Bertrand, Matteo Torsello, Donata Rimoldi, et al.
Cell Reports. Medicine|March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoeditingJulien Schmidt, Angela R Smith, Morgane Magnin, et al.
Journal of the National Cancer Institute|November 29, 2013
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinomaA Ari Hakimi, Helena Furberg, Emily C Zabor, et al.
The Journal of Experimental Medicine|June 11, 2014
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapyElisa Oricchio, Giovanni Ciriello, Man Jiang, et al.
Cancer Cell|April 25, 2020
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin LymphomaElie Dheilly, Elena Battistello, Natalya Katanayeva, et al.
Cancer Discovery|December 4, 2023
Cancer Evolution: A Multifaceted AffairGiovanni Ciriello, Luca Magnani, Sarah J Aitken, et al.
Blood|January 12, 2022
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALLMateusz Antoszewski, Nadine Fournier, Gustavo A Ruiz Buendía, et al.
Science Translational Medicine|June 30, 2017
Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphomaElisa Oricchio, Natalya Katanayeva, Maria Christine Donaldson, et al.
Cell|October 4, 2016
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T CellsMichael Boice, Darin Salloum, Frederic Mourcin, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Cell|August 10, 2019
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-KinaseViraj R Sanghvi, Josef Leibold, Marco Mina, et al.
American Journal of Human Genetics|October 18, 2016
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome SequencingBeryl Royer-Bertrand, Matteo Torsello, Donata Rimoldi, et al.
Cell Reports. Medicine|March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoeditingJulien Schmidt, Angela R Smith, Morgane Magnin, et al.
Journal of the National Cancer Institute|November 29, 2013
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinomaA Ari Hakimi, Helena Furberg, Emily C Zabor, et al.
The Journal of Experimental Medicine|June 11, 2014
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapyElisa Oricchio, Giovanni Ciriello, Man Jiang, et al.
Cancer Cell|April 25, 2020
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin LymphomaElie Dheilly, Elena Battistello, Natalya Katanayeva, et al.
Cancer Discovery|December 4, 2023
Cancer Evolution: A Multifaceted AffairGiovanni Ciriello, Luca Magnani, Sarah J Aitken, et al.
Blood|January 12, 2022
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALLMateusz Antoszewski, Nadine Fournier, Gustavo A Ruiz Buendía, et al.
Science Translational Medicine|June 30, 2017
Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphomaElisa Oricchio, Natalya Katanayeva, Maria Christine Donaldson, et al.
Cell|October 4, 2016
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T CellsMichael Boice, Darin Salloum, Frederic Mourcin, et al.
Pageof 8